73 related articles for article (PubMed ID: 3539117)
21. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
Prival MJ; Mitchell VD
Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
[TBL] [Abstract][Full Text] [Related]
22. Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis.
Oesch F; Protić-Sabljić M; Friedberg T; Klimisch HJ; Glatt HR
Carcinogenesis; 1983 Aug; 4(8):1031-8. PubMed ID: 6347425
[TBL] [Abstract][Full Text] [Related]
23. 7-Sulfooxymethyl-12-methylbenz[a]anthracene is an electrophilic mutagen, but does not appear to play a role in carcinogenesis by 7,12-dimethylbenz[a]anthracene or 7-hydroxymethyl-12-methylbenz[a]anthracene.
Surh YJ; Liem A; Miller EC; Miller JA
Carcinogenesis; 1991 Feb; 12(2):339-47. PubMed ID: 1899811
[TBL] [Abstract][Full Text] [Related]
24. In vitro metabolism of N-nitrodialkylamines.
Suzuki E; Mochizuki M; Sekiguchi N; Osabe M; Okada M
Jpn J Cancer Res; 1985 Jan; 76(1):28-36. PubMed ID: 3918908
[TBL] [Abstract][Full Text] [Related]
25. Effect of the nitro group conformation on the rat liver microsomal metabolism and bacterial mutagenicity of 2- and 9-nitroanthracene.
Fu PP; Heflich RH; Von Tungeln LS; Yang DT; Fifer EK; Beland FA
Carcinogenesis; 1986 Nov; 7(11):1819-27. PubMed ID: 3533305
[TBL] [Abstract][Full Text] [Related]
26. Activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to mutagenic metabolites.
Buonarati MH; Felton JS
Carcinogenesis; 1990 Jul; 11(7):1133-8. PubMed ID: 2197012
[TBL] [Abstract][Full Text] [Related]
27. Carcinogenicity and mutagenicity of N-nitroso compounds.
Lijinsky W
Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
[TBL] [Abstract][Full Text] [Related]
28. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
Ross MK; Pegram RA
Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
[TBL] [Abstract][Full Text] [Related]
29. Microsomal biotransformation of benzo[ghi]perylene, a mutagenic polycyclic aromatic hydrocarbon without a "classic" bay region.
Platt KL; Grupe S
Chem Res Toxicol; 2005 Apr; 18(4):700-10. PubMed ID: 15833030
[TBL] [Abstract][Full Text] [Related]
30. Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein.
Nelson SD; Omichinski JG; Iyer L; Gordon WP; Soderlund EJ; Dybing E
Biochem Biophys Res Commun; 1984 May; 121(1):213-9. PubMed ID: 6375666
[TBL] [Abstract][Full Text] [Related]
31. Possible involvement of a vicinal, non-bay-region dihydrodiol-epoxide in the activation of dibenzo[a,e]fluoranthene into bacterial mutagens.
Malaveille C; Hautefeuille A; Perin-Roussel O; Saguem S; Croisy-Delcey M; Zajdela F; Bartsch H
Carcinogenesis; 1984 Oct; 5(10):1263-6. PubMed ID: 6386214
[TBL] [Abstract][Full Text] [Related]
32. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
33. In vitro metabolism of o-aminoazotoluene and mutagenesis of Salmonella by the metabolites.
Degawa M; Kanazawa C; Hashimoto Y
Carcinogenesis; 1982; 3(10):1113-7. PubMed ID: 6756667
[TBL] [Abstract][Full Text] [Related]
34. Metabolic activation of 3-methylcholanthrene and its metabolites to products mutagenic to bacterial and mammalian cells.
Wood AW; Chang RL; Levin W; Thomas PE; Ryan D; Stoming TA; Thakker DR; Jerina DM; Conney AH
Cancer Res; 1978 Oct; 38(10):3398-404. PubMed ID: 356964
[No Abstract] [Full Text] [Related]
35. Metabolism of 1-nitrobenzo[a]pyrene by rat liver microsomes to potent mutagenic metabolites.
Chou MW; Heflich RH; Fu PP
Carcinogenesis; 1986 Nov; 7(11):1837-44. PubMed ID: 3769131
[TBL] [Abstract][Full Text] [Related]
36. In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens.
De Flora S; Bennicelli C; Zanacchi P; Camoirano A; Morelli A; De Flora A
Carcinogenesis; 1984 Apr; 5(4):505-10. PubMed ID: 6368036
[TBL] [Abstract][Full Text] [Related]
37. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of electrophilic metabolites by glutathione S-transferases and limitation of the system due to subcellular localization.
Glatt H; Oesch F
Arch Toxicol; 1977 Dec; 39(1-2):87-96. PubMed ID: 341852
[No Abstract] [Full Text] [Related]
39. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
Khudoley V; Malaveille C; Bartsch H
Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
[TBL] [Abstract][Full Text] [Related]
40. Mutagenicity of 3'-methyl-N,N-dimethyl-4-amino azobenzene metabolites and related compounds.
Mori Y; Niwa T; Hori T; Toyoshi K
Carcinogenesis; 1980 Feb; 1(2):121-7. PubMed ID: 22282990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]